AI Drug Discovery Specialist
An AI Drug Discovery Specialist leverages machine learning, deep learning, and generative AI to accelerate the identification, des…
Skill Guide
Graph Neural Networks (GNNs) for molecular and protein graphs are deep learning architectures that operate directly on graph-structured data, where atoms/nodes are connected by chemical bonds/edges to predict molecular properties or protein functions.
Scenario
A startup needs to filter virtual compound libraries for drug-like solubility before synthesis.
Scenario
A computational chemistry team must prioritize compounds for in vitro testing based on predicted binding to a target kinase.
Scenario
An R&D group needs to generate novel, synthesizable molecules with high target affinity and low toxicity, subject to multiple constraints.
PyG is the industry standard for research and prototyping. DGL offers strong scalability for production. Use JAX for high-performance computing on TPUs. PEFT is for adapting large pre-trained GNNs (like GEM) to small, domain-specific datasets.
RDKit is non-negotiable for molecular graph construction, featurization, and cheminformatics. Use OpenBabel for format conversion. BioPandas parses PDB/mmCIF files for protein structures. OpenMM generates dynamic 3D conformations.
MoleculeNet provides standardized datasets (e.g., BBBP, Tox21). OGB-molpcba is for large-scale multi-task prediction. UniProt is the protein sequence knowledgebase. Use AlphaFold structures to bootstrap protein graphs when experimental data is missing.
Answer Strategy
Use a three-pronged approach: 1) Data-level (stratified k-fold, oversampling with SMOTE for graphs or focal loss), 2) Model-level (architecture choice with high-capacity GNNs like GAT with dropout), 3) Evaluation-level (precision-recall AUC, enrichment factors in virtual screening). Emphasize that standard accuracy is misleading; focus on hit rate in top-ranked predictions for chemists.
Answer Strategy
Test the candidate's ability to bridge ML and domain knowledge. Strategy: 1) Acknowledge the expert's domain insight. 2) Use explainability tools (GNNExplainer, attention visualization) to identify which substructure the model is focusing on. 3) Compare the model's learned features with known pharmacophores. 4) If misalignment is found, propose re-featurization (e.g., adding donor/acceptor flags) or constraint-based training. The goal is collaborative debugging, not defensive justification.
1 career found
Try a different search term.